Real-world smartphone keyboard interactions discriminates between different levels of disability in multiple sclerosis

被引:0
|
作者
Lam, K.
Hoeijmakers, A.
Licitra, G.
Meijer, K.
Killestein, J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-114
引用
收藏
页码:281 / 282
页数:2
相关论文
共 50 条
  • [31] Exploring the Correlation between Disability Status and Brain Volumetric Measurements Using Real-World Retrospective Magnetic Resonance Images in People with Multiple Sclerosis
    Khan, Hamza
    Giraldo, Diana
    Beirinckx, Quinten
    Sijbers, Jan
    Woodruff, Henry
    Lambin, Philippe
    Peeters, Liesbet
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 841 - 842
  • [32] Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital Study
    Lasse Skovgaard
    Philipp Trénel
    Katrine Westergaard
    Astrid Karnøe Knudsen
    Neurology and Therapy, 2023, 12 : 1335 - 1357
  • [33] Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital Study
    Skovgaard, Lasse
    Trenel, Philipp
    Westergaard, Katrine
    Knudsen, Astrid Karnoe
    NEUROLOGY AND THERAPY, 2023, 12 (04) : 1335 - 1357
  • [34] Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register
    Lepore, V
    Bosetti, C.
    Santucci, C.
    Iaffaldano, P.
    Trojano, M.
    Mosconi, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (02) : 567 - 578
  • [35] Cognitive Function at Different Levels of Neurologic Disability in Veterans with Multiple Sclerosis
    Dux, M. C.
    Lee-Wilk, T.
    Tyner, C.
    Culpepper, W. J.
    Wallin, M.
    Bever, C. T.
    Royal, W., III
    CLINICAL NEUROPSYCHOLOGIST, 2015, 29 (03) : 355 - 355
  • [36] Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
    Wiendl, Heinz
    Spelman, Tim
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojan, Maria
    Su, Ray
    Campbell, Nolan
    Ho, Pei-Ran
    Licata, Stephanie
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) : 719 - 728
  • [37] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [38] Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population
    Coban, Hamza
    Germaine, Sarah
    Dimaandal, Ian
    Haberli, Nicholas
    Padam, Charanpreet
    Creed, Marina A.
    Imitola, Jaime
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [39] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, H.
    Riise, T.
    Myhr, K. -M.
    Grytten, N.
    Wergeland, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 712 - 712
  • [40] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, Hilde
    Riise, Trond
    Myhr, Kjell-Morten
    Grytten, Nina
    Wergeland, Stig
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)